These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11120281)

  • 21. Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients.
    Abou-Jaoude MM; Irani-Hakime N; Ghantous I; Najm R; Afif C; Almawi WY
    Transplant Proc; 2003 Nov; 35(7):2748-9. PubMed ID: 14612103
    [No Abstract]   [Full Text] [Related]  

  • 22. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
    Pascual J; Ortuño J;
    Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
    [No Abstract]   [Full Text] [Related]  

  • 23. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
    Forsythe J
    Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful results after 3 years' tacrolimus immunosuppression in ABO-incompatible kidney transplantation recipients in Japan.
    Takahashi K; Takahara S; Uchida K; Oshima S; Toma H; Sonoda T;
    Transplant Proc; 2002 Aug; 34(5):1604-5. PubMed ID: 12176502
    [No Abstract]   [Full Text] [Related]  

  • 25. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.
    Ciancio G; Garcia-Morales R; Burke GW; Roth D; Esquenazi V; Tzakis A; Miller J
    Transplant Proc; 1999; 31(1-2):679. PubMed ID: 10083291
    [No Abstract]   [Full Text] [Related]  

  • 26. Current advantage of FK 506 in cadaveric kidney transplantation.
    Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
    Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
    Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tacrolimus therapy for ABO-incompatible kidney transplantation.
    Takahashi K; Saito K; Sonda K; Nakagawa Y; Katagiri A; Tomita Y; Tanigawa T; Takeda M
    Transplant Proc; 1998 Jun; 30(4):1219-20. PubMed ID: 9636495
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of tacrolimus in renal transplant recipients with immunoglobulin-A nephropathy.
    Suzuki K; Tanabe K; Tokumoto T; Shimizu T; Ishikawa N; Yagisawa T; Honda K; Nihei H; Toma H
    Transplant Proc; 2000 Nov; 32(7):1730-2. PubMed ID: 11119910
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of tacrolimus on the outcome of renal transplantation with donor-specific blood transfusion.
    Miura S; Okazaki H; Sato T; Amada N; Ohashi Y
    Transplant Proc; 1998 Jun; 30(4):1212-3. PubMed ID: 9636492
    [No Abstract]   [Full Text] [Related]  

  • 31. Kidney transplantation from living related donors.
    Mouquet C; Benalia H; Barrou B; Ourahma S; Luciani J; Coriat P; Bitker MO
    Transplant Proc; 1996 Oct; 28(5):2801. PubMed ID: 8908065
    [No Abstract]   [Full Text] [Related]  

  • 32. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997.
    Alfani D; Pretagostini R; Rossi M; Poli L; De Simone P; Colonnello M; Novelli G; Urbano D; Venettoni S; Persijn G; Smits J; Cortesini R
    Transplant Proc; 1997 Dec; 29(8):3399-401. PubMed ID: 9414764
    [No Abstract]   [Full Text] [Related]  

  • 33. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
    Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
    Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
    [No Abstract]   [Full Text] [Related]  

  • 34. Successful treatment of 115 pediatric renal transplant recipients with tacrolimus-based immunosuppressive therapy: a 7-year multicenter study in Japan.
    Hasegawa A; Oshima S; Takahashi K; Uchida K; Ito K; Sonoda T
    Transplant Proc; 2005 May; 37(4):1769-70. PubMed ID: 15919460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results and complications after living related kidney transplantation in Hungary: 30 years' experience.
    Dallos G; Hídvégi M; Kósa G; Kóbori L; Alföldy F; Perner F; Járay J
    Transplant Proc; 2010; 42(6):2312-4. PubMed ID: 20692470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of donor age on outcome of living related kidney transplantation.
    Kim YL; Kim JH; Kwon TH; Cho DK; Kim YW; Chang SI; Chung SK; Chang SK
    Transplant Proc; 1996 Jun; 28(3):1580-1. PubMed ID: 8658793
    [No Abstract]   [Full Text] [Related]  

  • 37. The impact of IL2ra induction therapy in kidney transplantation using tacrolimus- and mycophenolate-based immunosuppression.
    Gralla J; Wiseman AC
    Transplantation; 2010 Sep; 90(6):639-44. PubMed ID: 20595929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in renal transplantation: 1-year actuarial follow-up.
    Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Marsh JW; McCauley J; Johnston J; Randhawa P; Irish W; Gritsch HA; Naraghi R; Hakala TR; Fung JJ; Starzl TE
    Transplant Proc; 1999; 31(1-2):1134. PubMed ID: 10083507
    [No Abstract]   [Full Text] [Related]  

  • 39. Analysis of the factors affecting survival of renal transplant recipients.
    Kim ST; Lee S; Kim JS; Ha J; Chung JK; Kim SJ
    Transplant Proc; 1998 Nov; 30(7):3086-7. PubMed ID: 9838361
    [No Abstract]   [Full Text] [Related]  

  • 40. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.